People Background Check
Find People:

Eric R Gundersen, Age 49Parsippany, NJ

Get Report
Known as:
Erick R Gundersen Erick R Gunderson
Related to:
Joseph N Ficchi 35

Eric Gundersen Phones & Addresses

Denville, NJ

33 Woodland Dr, Vernon, NJ 07462 (973) 827-3839 (973) 827-8619 (973) 827-3203

113 Drew Rd, Sussex, NJ 07461 (973) 209-4511 (973) 827-5605

32 Wits End Dr, Hamburg, NJ 07419 (973) 209-4511

Highland Lakes, NJ

Mentions for Eric R Gundersen

Eric Gundersen resumes & CV records

Resumes

Eric Gundersen Photo 38

Eric Gundersen

Eric Gundersen Photo 39

Eric Gundersen

Eric Gundersen Photo 40

Eric Gundersen

Publications & IP owners

Wikipedia

Eric Gundersen Photo 45

Erik Gundersen

Erik Gundersen (born 8 October 1959, in Esbjerg, Denmark was a speedway rider in the late 1970s and 1980s. Gundersen was the Speedway World Championship

Us Patents

2,3,5-Substituted Biphenyls Useful In The Treatment Of Insulin Resistance And Hyperglycemia

US Patent:
6451827, Sep 17, 2002
Filed:
Jan 26, 2001
Appl. No.:
09/771469
Inventors:
John A. Butera - Clarskburg NJ
Craig E. Caufield - New York NY
Russell F. Graceffa - Hampton NH
Alexander Greenfield - Princeton Junction NJ
Eric G. Gundersen - Plainsboro NJ
Lisa Marie Havran - Bordentown NJ
Alan H. Katz - Lawrenceville NJ
Joseph R. Lennox - Morrixville NC
Scott C. Mayer - Robbinsville NJ
Robert E. McDevitt - Somerset NJ
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 3144
US Classification:
514357, 546300, 544162, 548217, 5483355, 548469, 549491, 5142378, 514375, 514399, 514415, 514471
Abstract:
This invention provides compounds of Formula I having the structure wherein: B, C, D, and R are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.

2,3,5-Substituted Biphenyls Useful In The Treatment Of Insulin Resistance And Hyperglycemia

US Patent:
6765021, Jul 20, 2004
Filed:
Aug 9, 2002
Appl. No.:
10/215438
Inventors:
John A. Butera - Clarkburg NJ
Craig E. Caufield - New York NY
Russell F. Graceffa - Hampton NH
Alexander Greenfield - Princeton Junction NJ
Eric G. Gundersen - Plainsboro NJ
Lisa Marie Havran - Bordentown NJ
Alan H. Katz - Lawrenceville NJ
Joseph R. Lennox - Morrisville NC
Scott C. Mayer - Robbinsville NJ
Robert E. McDevitt - Somerset NJ
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 3117
US Classification:
514596, 564 48, 562457, 560 19, 560 43, 514572, 514485, 514476
Abstract:
This invention provides compounds of formula I having the structure wherein: B, D, C, and R as defined herein.

Substituted Naphthyl Indole Derivatives As Inhibitors Of Plasminogen Activator Inhibitor Type-1 (Pai-1)

US Patent:
6800654, Oct 5, 2004
Filed:
Jun 13, 2002
Appl. No.:
10/171041
Inventors:
Scott Christian Mayer - Bridgewater NJ
Eric Gould Gundersen - Hightstown NJ
Hassan Mahmoud Elokdah - Yardley PA
David LeRoy Crandall - Doylestown PA
Assignee:
Wyeth - Madison NJ
International Classification:
C07D20904
US Classification:
514381, 548252, 548243, 548413, 548414, 548491, 549356, 549414, 514414, 514415
Abstract:
This invention provides PAI-1 inhibiting compounds of Formula I: wherein: R , R , R , and R are eachH, alkyl,, alkanoyl, halo, OH, aryl optionally substituted with R , perfluoroalkyl, alkoxy, amino, alkylamino, dialkylamino, perfluoroalkoxy; R is H, alkyl, perfluoroalkyl, aryl optionally substituted with R , alkanoyl, aroyl optionally substituted with R ; R is H, alkyl, alkylaryl, benzyl optionally substituted with R , alkanoyl, aroyl optionally substituted with R ; R is H, alkyl, alkylaryl, aryl optionally substituted with R ; n is 0-6; A is COOH, or an acid mimic such as tetraazole, SO H, PO H , tetronic acid, etc. ; R is H, alkyl, cycloalkyl, alkanoyl, halo, OH, perfluoroalkyl, alkoxy, amino, alkylamino, dialkylamino, perfluoroalkoxy; or a pharmaceutically acceptable salt thereof; as well as pharmaceutical compositions and methods of treatment using these compounds.

Substituted Naphthyl Indole Derivatives As Inhibitors Of Plasminogen Activator Inhibitor Type-1 (Pai-1)

US Patent:
6939886, Sep 6, 2005
Filed:
Jul 20, 2004
Appl. No.:
10/894618
Inventors:
Scott Christian Mayer - Bridgewater NJ, US
Eric Gould Gundersen - Royersford PA, US
Hassan Mahmoud Elokdah - Yardley PA, US
David LeRoy Crandall - Doylestown PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K031/404
C07D209/04
C07D403/02
US Classification:
514381, 548243, 548252, 548413, 548414, 548491, 549356, 549414, 514414, 514415
Abstract:
This invention provides PAI-1 inhibiting compounds of Formula I: wherein: R, R, R, and Rare each H, alkyl, alkanoyl, halo, OH, aryl optionally substituted with R, perfluoroalkyl, alkoxy, amino, alkylamino, dialkylamino, perfluoroalkoxy; Ris H, alkyl, perfluoroalkyl, aryl optionally substituted with R, alkanoyl, aroyl optionally substituted with R; Ris H, alkyl, alkylaryl, benzyl optionally substituted with R, alkanoyl, aroyl optionally substituted with R; Ris H, alkyl, alkylaryl, aryl optionally substituted with R; n is 0-6; A is COOH, or an acid mimic such as tetraazole, SOH, POH, tetronic acid, etc. ; Ris H, alkyl, cycloalkyl, alkanoyl, halo, OH, perfluoroalkyl, alkoxy, amino, alkylamino, dialkylamino, perfluoroalkoxy; or a pharmaceutically acceptable salt thereof; as well as pharmaceutical compositions and methods of treatment using these compounds.

Substituted Naphthyl Indole Derivatives As Inhibitors Of Plasminogen Activator Inhibitor Type-1 (Pai-1)

US Patent:
7351730, Apr 1, 2008
Filed:
Jun 22, 2005
Appl. No.:
11/158881
Inventors:
Scott Christian Mayer - Bridgewater NJ, US
Eric Gould Gundersen - Royersford PA, US
Hassan Mahmoud Elokdah - Yardley PA, US
David LeRoy Crandall - Doylestown PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/404
C07D 209/04
C07D 403/02
US Classification:
514381, 548243, 548252, 548413, 548414, 548491, 549356, 549414, 514414, 514415
Abstract:
This invention provides PAI-1 inhibiting compounds of Formula I:.

2,3,5-Substituted Biphenyls Useful In The Treatment Of Insulin Resistance And Hyperglycemia

US Patent:
6214877, Apr 10, 2001
Filed:
May 10, 1999
Appl. No.:
9/307850
Inventors:
John A. Butera - Clarskburg NJ
Craig E. Caufield - New York NY
Russell F. Graceffa - Hampton NH
Alexander Greenfield - Princeton Junction NJ
Eric G. Gundersen - Plainsboro NJ
Lisa Marie Havran - Bordentown NJ
Alan H. Katz - Lawrenceville NJ
Joseph R. Lennox - Morrixville NC
Scott C. Mayer - Robbinsville NJ
Robert E. McDevitt - Somerset NJ
International Classification:
A61K 31166
C07C23544
US Classification:
514563
Abstract:
This invention provides compounds of Formula I having the structure ##STR1## wherein: B, C, D, and R. sup. 1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.

Possible Relatives

David F Gundersen  Deborah P Gundersen  Daniel C Gundersen  Aaron J Gundersen  Eleanor A Gundersen  Emily Gundersen  Erik C Gundersen  Eric Z Stander  Eric L Standifer  Eric I Johnston 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.